Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Caspofungin multichem |
| Active Ingredient: | Caspofungin acetate 55.48mg equivalent to caspofungin 50mg |
| Dosage Form: | Powder for infusion concentrate |
| New Zealand Sponsor: | Multichem NZ Limited |
| Manufacturer: | Demo SA Pharmaceutical Industry, Athens, Greece |
| Product: | Caspofungin multichem |
| Active Ingredient: | Caspofungin acetate 77.67mg equivalent to caspofungin 70mg |
| Dosage Form: | Powder for infusion concentrate |
| New Zealand Sponsor: | Multichem NZ Limited |
| Manufacturer: | Demo SA Pharmaceutical Industry, Athens, Greece |
| Product: | Ferriprox |
| Active Ingredient: | Deferiprone 1000mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Apotex NZ Limited |
| Manufacturer: | Apotex Inc, Toronto, Canada |
Dated this 31st day of January 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).